Simon TG - Search Results

1

American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease.

Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ, Kappus MR, Keating SE, Pugh CJA, Rotman Y, Simon TG, Vilar-Gomez E, Wong VW, Schmitz KH. Stine JG, et al. Among authors: simon tg. Hepatol Commun. 2023 Mar 30;7(4):e0108. doi: 10.1097/HC9.0000000000000108. eCollection 2023 Apr 1. Hepatol Commun. 2023. PMID: 36995998 Free PMC article. Review.

2

Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.

Simon TG, Corey KE, Chung RT, Giugliano R. Simon TG, et al. Dig Dis Sci. 2016 Dec;61(12):3425-3435. doi: 10.1007/s10620-016-4330-z. Epub 2016 Oct 6. Dig Dis Sci. 2016. PMID: 27714510 Review.

3

Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and Dysfunction.

Simon TG, Bamira DG, Chung RT, Weiner RB, Corey KE. Simon TG, et al. Obesity (Silver Spring). 2017 Aug;25(8):1313-1316. doi: 10.1002/oby.21879. Obesity (Silver Spring). 2017. PMID: 28745025 Free PMC article.

4

The MELD-Plus: A generalizable prediction risk score in cirrhosis.

Kartoun U, Corey KE, Simon TG, Zheng H, Aggarwal R, Ng K, Shaw SY. Kartoun U, et al. Among authors: simon tg. PLoS One. 2017 Oct 25;12(10):e0186301. doi: 10.1371/journal.pone.0186301. eCollection 2017. PLoS One. 2017. PMID: 29069090 Free PMC article.

5

MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD).

Simon TG, Kartoun U, Zheng H, Chan AT, Chung RT, Shaw S, Corey KE. Simon TG, et al. Hepatol Commun. 2017 Jul;1(5):429-438. doi: 10.1002/hep4.1051. Epub 2017 May 22. Hepatol Commun. 2017. PMID: 29085919 Free PMC article.

6

Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.

Simon TG, King LY, Chong DQ, Nguyen LH, Ma Y, VoPham T, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Khalili H, Chung RT, Zhang X, Chan AT. Simon TG, et al. Hepatology. 2018 May;67(5):1797-1806. doi: 10.1002/hep.29660. Epub 2018 Mar 26. Hepatology. 2018. PMID: 29152763 Free PMC article.

7

Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis.

Simon TG, Trejo MEP, McClelland R, Bradley R, Blaha MJ, Zeb I, Corey KE, Budoff MJ, Chung RT. Simon TG, et al. Int J Cardiol. 2018 May 15;259:198-204. doi: 10.1016/j.ijcard.2018.01.046. Int J Cardiol. 2018. PMID: 29579601 Free PMC article.

8

The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.

Simon TG, Corey KE, Cannon CP, Blazing M, Park JG, O'Donoghue ML, Chung RT, Giugliano RP. Simon TG, et al. Int J Cardiol. 2018 Nov 1;270:245-252. doi: 10.1016/j.ijcard.2018.05.087. Epub 2018 May 26. Int J Cardiol. 2018. PMID: 29903515 Free PMC article. Clinical Trial.

9

Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.

Simon TG, Ma Y, Ludvigsson JF, Chong DQ, Giovannucci EL, Fuchs CS, Meyerhardt JA, Corey KE, Chung RT, Zhang X, Chan AT. Simon TG, et al. JAMA Oncol. 2018 Dec 1;4(12):1683-1690. doi: 10.1001/jamaoncol.2018.4154. JAMA Oncol. 2018. PMID: 30286235 Free PMC article.

10

Simon TG, Deng X, Liu CT, Chung RT, Long MT. Simon TG, et al. Liver Int. 2019 Jun;39(6):1022-1026. doi: 10.1111/liv.14039. Epub 2019 Feb 17. Liver Int. 2019. PMID: 30597691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page